Global Cord Blood (Global Cord Blood) Cash And Cash Equivalents : $1,049.9 Mil (As of Mar. 2022)

View and export this data going back to 2007. Start your Free Trial

What is Global Cord Blood Cash And Cash Equivalents?

Global Cord Blood's quarterly cash and cash equivalents increased from Sep. 2021 ($989.83 Mil) to Dec. 2021 ($1,021.31 Mil) and increased from Dec. 2021 ($1,021.31 Mil) to Mar. 2022 ($1,049.87 Mil).

Global Cord Blood's annual cash and cash equivalents increased from Mar. 2020 ($779.63 Mil) to Mar. 2021 ($933.17 Mil) and increased from Mar. 2021 ($933.17 Mil) to Mar. 2022 ($1,049.87 Mil).

Global Cord Blood Cash And Cash Equivalents Historical Data

The historical data trend for Global Cord Blood's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Cord Blood Cash And Cash Equivalents Chart

Global Cord Blood Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Cash And Cash Equivalents

Get a 7-Day Free Trial

672.84

744.63

779.63

933.17

1,049.87

Global Cord Blood Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Cash And Cash Equivalents	Get a 7-Day Free Trial															933.17	970.80	989.83	1,021.31	1,049.87

Global Cord Blood Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Global Cord Blood (OTCPK:CORBF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Global Cord Blood Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Global Cord Blood's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Cord Blood (Global Cord Blood) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Global Cord Blood Corp (OTCPK:CORBF) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG

Website

http://www.globalcordbloodcorp.com

Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants.

Executives

Kent C Mccarthy	10 percent owner, other: Mbr 13(d) grp own 10% plus	930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Private Equity Fund Ii Lp	10 percent owner	5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205
7-2010 Grat 5 Under Kent C. Mccarthy Grat Tr Dtd 4-23-2010	other: 13 (d) group owning > 10%	7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
7-2010 Grat 6 Under Kent C Mccarthy Grat Tr Dtd 4-23-2010	10 percent owner, other: Member of 13(d) group owning m	7335 COTTONWOOD, SHAWNEE KS 66216
Mccarthy Family Sd, Llc	10 percent owner, other: 13 (d) group owning > 10%	7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jhab Fund Ii, Llc	other: 13(d) group owning > 10%	7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jhab Management Ii, Llc	other: 13(d) group owning > 10%	7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jcf Co Lf, L.p.	other: 13(d) group owning > 10%	930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Capital Management Llc	other: Member of the group	13021 W 74TH ST, SHAWNEE KS 66216
Jayhawk China Fund Cayman Ltd	other: Member of the group	930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Private Equity Gp Ii, L.p.	10 percent owner	5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205
Jayhawk Private Equity, Llc	10 percent owner	5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205